glp-1 fatty liver and Your Liver: What to Monitor While on Semaglutide or Tirzepatide GLP-1 Receptor Agonists in Non-Alcoholic

Description

Of note, in addition to glucagon, the pancreas contained a large peptide with immunoreactive determinants for both GLP-1 and GLP-2 (but not glucagon), consistent with incompletely cleaved proglucagon (major proglucagon fragment [MPGF]) (Figure 3, A and C, and ref

Whilst oral bioavailability is relatively poor (less than 5% reaches systemic circulation due to extensive first-pass metabolism), sufficient absorption occurs to produce measurable pharmacological effects in research settings

1 The different GLP-1 RAs vary in the number of antibodies seen in clinical trials, with exenatide (once weekly) having the greatest and dulaglutide and albiglutide having the least